MYELODYSPLASIA
Clinical trials for MYELODYSPLASIA explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASIA trials appear
Sign up with your email to follow new studies for MYELODYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New stem cell transplant method aims to reduce Graft-Versus-Host disease
Disease control OngoingThis study tests a stem cell transplant for people with blood cancers like leukemia and lymphoma. Doctors remove certain immune cells from donor stem cells to help the body accept the transplant and lower the risk of serious side effects. The goal is to improve survival and reduc…
Matched conditions: MYELODYSPLASIA
Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Apr 30, 2026 16:01 UTC
-
New stem cell transplant study offers hope for blood cancer patients
Disease control OngoingThis study tests a stem cell transplant using blood cells from a half-matched (haploidentical) donor for people with certain blood cancers like leukemia and lymphoma. The goal is to see if this approach helps patients survive longer and recover their immune system. The trial invo…
Matched conditions: MYELODYSPLASIA
Phase: PHASE3 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
Expanded cord blood cells aim to speed recovery after cancer treatment
Disease control OngoingThis study tests a new way to grow cord blood stem cells in the lab before transplanting them into people with high-risk blood cancers. The goal is to help the body rebuild healthy blood cells faster after high-dose chemotherapy. About 22 adults and children up to age 55 are taki…
Matched conditions: MYELODYSPLASIA
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC